Treatment of electrolyte disorders in adult patients in the intensive care unit

被引:176
作者
Kraft, MD
Btaiche, IF
Sacks, GS
Kudsk, KA
机构
[1] Univ Michigan, Hlth Syst, Dept Pharm Serv, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Coll Pharm, Dept Clin Sci, Ann Arbor, MI 48109 USA
[3] Univ Wisconsin, Sch Pharm, Pharm Pract Div, Madison, WI 53706 USA
[4] Univ Wisconsin, Dept Surg, Madison, WI 53706 USA
关键词
calculations; critical illness; dosage; electrolytes; equations; methodology; mortality; protocols; water-electrolyte imbalance;
D O I
10.2146/ajhp040300
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The treatment of electrolyte disorders in adult patients in the intensive care unit (ICU), including guidelines for correcting specific electrolyte disorders, is reviewed. Summary. Electrolytes are involved in many metabolic and homeostatic functions. Electrolyte disorders are common in adult patients in the ICU and have been associated with increased morbidity and mortality, as has the improper treatment of electrolyte disorders. A limited number of prospective,. randomized, controlled studies have been conducted evaluating the optimal treatment of electrolyte disorders. Recommendations for treatment of electrolyte disorders in adult patients in the ICU are provided based on these studies, as well as case reports, expert opinion, and clinical experience. The etiologies of and treatments for hyponatremia hypotonic and hypernatremia (hypovolemic, isovolemic, and hypervolemic), hypokalemia and hyperkalemia, hypophosphatemia and hyperphosphatemia, hypocalcemia and hypercalcemia, and hypomagnesemia and hypermagnesemia are discussed, and equations for determining the proper dosages for adult patients in the ICU are provided. Treatment is often empirical, based on published literature, expert recommendations, and the patient's response to the initial treatment. Actual electrolyte correction requires individual adjustment based on the patient's clinical condition and response to therapy. Clinicians should be knowledgeable about electrolyte homeostasis and the underlying pathophysiology of electrolyte disorders in order to provide the optimal therapy to patients. Conclusion. Treatment of electrolyte disorders is often empirical, based on published literature, expert opinion and recommendations, and patient's response to the initial treatment. Clinicians should be knowledgeable about electrolyte homeostasis and the underlying pathophysiology of electrolyte disorders to provide optimal therapy for patients.
引用
收藏
页码:1663 / 1682
页数:20
相关论文
共 176 条
[1]   Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol - Clinical, endoscopic, and histopathologic findings [J].
Abraham, SC ;
Bhagavan, BS ;
Lee, LA ;
Rashid, A ;
Wu, TT .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (05) :637-644
[2]   Primary care -: Hypernatremia [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1493-1499
[3]   Primary care:: Hyponatremia. [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) :1581-1589
[4]  
Agarwal A, 1999, NEW ENGL J MED, V340, P154
[5]   DISORDERS OF CALCIUM AND MAGNESIUM HOMEOSTASIS [J].
AGUS, ZS ;
WASSERSTEIN, A ;
GOLDFARB, S .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (03) :473-488
[6]   INDOMETHACIN IN THE TREATMENT OF LITHIUM-INDUCED NEPHROGENIC DIABETES-INSIPIDUS [J].
ALLEN, HM ;
JACKSON, RL ;
WINCHESTER, MD ;
DECK, LV ;
ALLON, M .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (05) :1123-1126
[7]   IMPAIRED RELEASE OF PARATHYROID-HORMONE IN MAGNESIUM-DEFICIENCY [J].
ANAST, CS ;
WINNACKER, JL ;
FORTE, LR ;
BURNS, TW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (04) :707-717
[8]   HYPONATREMIA - A PROSPECTIVE ANALYSIS OF ITS EPIDEMIOLOGY AND THE PATHOGENETIC ROLE OF VASOPRESSIN [J].
ANDERSON, RJ ;
CHUNG, HM ;
KLUGE, R ;
SCHRIER, RW .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (02) :164-168
[9]   TREATMENT OF REFRACTORY HYPOPHOSPHATEMIA [J].
ANDRESS, DL ;
VANNATTA, JB ;
WHANG, R .
SOUTHERN MEDICAL JOURNAL, 1982, 75 (06) :766-767
[10]  
Androgue HJ, 1997, INTENS CARE MED, V23, P309